The Nations Law Firm is a national catastrophic injury and
pharmaceutical litigation firm.
Not exact matches
The
firms to have made it onto the Department of Health's civil
litigation and arbitration in medicine and
pharmaceuticals (CLAMP) panel are Peters & Peters, Capsticks, Hill Dickinson, Berwin Leighton Paisner (BLP) and Trowers & Hamlins.
Ms. Werkema recently joined the
firm's
pharmaceutical litigation group, where she represents clients and their families adversely affected by Granuflo, a product used in dialysis that has caused countless deaths due to misleading and inadequate use instructions provided to health care professionals by its manufacturer.
Our
firm is respected as a leader in products liability
litigation and has a solid history of successfully representing plaintiffs in
pharmaceutical litigation.
As an attorney with the New York
litigation firm of Whitman Breed Abbott & Morgan (1990 - 2000), Mr. Scagnelli handled intellectual property counseling work and
litigation for industrial clients, including
Pharmaceutical Formulations, Inc. in Edison, New Jersey, then the second largest private label
pharmaceutical company in the United States.
The Union Leader editorial board blasts New Hampshire Attorney General Joe Foster's contingency fee arrangement with the Cohen Milstein plaintiffs»
firm for «prescription opioid»
litigation against
pharmaceutical companies.
The attorneys at our
firm have also represented clients in a variety of other class action cases, ranging from mass tort
litigation, including asbestos claims, to
pharmaceutical and medical devices.
Sindhu Daniel manages the
firm's
Pharmaceutical Litigation Group and has a passion for representing people harmed by big
pharmaceutical companies which have marketed their products as safe when they are not or have otherwise misrepresented the efficacy and toxicity of their medical commodities.
He has extensive experience in representing a major media company, financial institutions, brand name
pharmaceutical manufacturers, accounting
firms, law
firms, and a variety of other companies and professionals in federal and state
litigation, including in matters involving antitrust law, securities law, corporate governance,
pharmaceutical pricing, contract disputes, accountants liability, legal malpractice and communications law.
Prior to joining Lewis Wagner, Meghan was an associate in the New York
firm Traub Lieberman Straus & Shrewsberry's insurance coverage group, where she represented insurance company clients in insurance coverage
litigation, and advised insurers on exposure and liability issues in wide array of tort and commercial contexts, including mass tort and class action
litigation involving
pharmaceuticals, chemical, transportation, news and entertainment, and oil and gas; environmental suits; FDA compliance claims; unfair competition and false advertising claims; intellectual property claims; construction defect; personal injury; product liability; and associated breach of contract claims.
The Lanier Law
Firm's
pharmaceutical litigation team is taking a leading role in partnering with state and local governments across the country...
As the head of Baron & Budd's asbestos and
pharmaceutical litigation teams, Baron has helped build the
firm's reputation as a watchdog for consumer protection.
Both attorneys bring years of experience in the life sciences,
pharmaceutical, medical device, and biotechnology sectors, which will help strengthen the
firm «s patent prosecution, opinion and IP
litigation expertise in these areas.
Our
firm has handled
litigation against some of the largest
pharmaceutical manufacturers in the world.
The publication highlights some of the
firm's high - profile representations, including its role as lead national counsel for an international
pharmaceutical company in hormone replacement therapy
litigation, Wright's representation of Ford against allegations of unintended acceleration and faulty spark plugs, and Troyer's defense of Wells Fargo in a nationwide class action and an associated individual action and his representation of a manufacturing company in a toxic tort case.
Before joining Arent Fox in 2004, Ricardo was a partner in a major law
firm in the city of Caracas, Venezuela where he represented various
pharmaceutical, food, and entertainment companies doing business in Venezuela and South America in areas including foreign investment requirements and compliance, regulatory compliance with focus on food and
pharmaceuticals, and intellectual property — namely trademark protection and
litigation, data access, and privacy and patent
litigation (mostly design patent).
Danielle Grant - Keane is an associate in the
firm's Patent
Litigation practice with experience litigating patents in the areas of biotechnology and
pharmaceuticals.
His experience in these areas stems from his time at the venerated plaintiffs» law
firm Lopez, Hodes, Restaino, Milman & Skikos, where he handled high - profile mass tort
litigation and
pharmaceutical injury cases against such behemoth companies as Wal - mart, Merck & Co. and Halliburton Company.
Our reputation as one of the top class action defense
firms in the country results from our significant experience in defending against alleged class actions across a broad range of
pharmaceutical and other products
litigation, as well as antitrust, employment and securities
litigation.
Top talent at the
firm includes distinguished trial lawyer Michael Lehman, who heads the
firm's medical malpractice and physician advocacy group and is considered a top expert in the state in high - stakes medical malpractice cases,
pharmaceutical and medical device product liability claims and
litigation related to the aviation industry.
The Lanier Law
Firm is a pioneer in its involvement in numerous
pharmaceutical liability
litigations, with an extremely successful track record.
With a reputation for trial readiness, the global
litigation firm serves health, science and technology clients in the
pharmaceutical and medical device, energy and consumer product industries, among others.
For many intellectual property
firms, concerns
pharmaceutical litigation would dry up, removing a core source of income for many, appear to be as yet unfounded.
During law school, he joined the juggernaut
litigation firm Girardi - Keese and worked multi-million dollar
pharmaceutical and products liability cases.